Suven Life Sciences Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 2.46 | 2.66 | 3.18 |
| Operating Expense | 15.87 | 16.38 | 14.91 |
| Net Profit | -14.78 | -15.07 | -13.27 |
| Net Profit Margin | -600.81 | -566.54 | -417.30 |
| Earning Per Share | -0.68 | -0.69 | -0.61 |
| EBIDTA | -13.41 | -13.72 | -11.73 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 2.46 |
| Operating Expense | 15.87 |
| Net Profit | -14.78 |
| Net Profit Margin | -600.81 |
| Earning Per Share | -0.68 |
| EBIDTA | -13.41 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 6.66 | 11.69 | 13.54 |
| Operating Expenses Annual | 58.59 | 42.63 | 41.28 |
| Operating Profit Annual | -41.21 | -2.35 | -13.29 |
| Interest Annual | 0.05 | 0.16 | 0.29 |
| Depreciation | 5.79 | 6.47 | 6.52 |
| Net Profit Annual | -47.08 | -8.01 | -20.13 |
| Tax Annual | TBA | -1.00 | TBA |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 6.66 |
| Operating Expenses Annual | 58.59 |
| Operating Profit Annual | -41.21 |
| Interest Annual | 0.05 |
| Depreciation | 5.79 |
| Net Profit Annual | -47.08 |
| Tax Annual | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 4.40 | 26.70 | 2.90 |
| Cash Flow from Operations | -47.39 | -20.56 | -22.92 |
| Cash Flow from Investing | 44.21 | -0.68 | -348.82 |
| Cash Flow from Financing | -0.76 | -1.05 | 395.54 |
| Cash Flow at the End | 0.46 | 4.40 | 26.70 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 4.40 |
| Cash Flow from Operations | -47.39 |
| Cash Flow from Investing | 44.21 |
| Cash Flow from Financing | -0.76 |
| Cash Flow at the End | 0.46 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | -692.04 | -122.16 | -154.87 |
| PBIT Margin (%) | -779.43 | -177.76 | -203.18 |
| PBT Margin (%) | 4,416.82 | 562.87 | 304.94 |
| Net PROFIT Margin (%) | -706.91 | -68.52 | -148.67 |
| Return On Networth / Equity (%) | -6.33 | -2.36 | -4.20 |
| Return On Networth /Employed (%) | -6.30 | -2.44 | -4.11 |
| Return On Assets (%) | -7.07 | -0.69 | -2.97 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 0.01 | 0.01 | 0.02 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | -692.04 |
| PBIT Margin (%) | -779.43 |
| PBT Margin (%) | 4,416.82 |
| Net PROFIT Margin (%) | -706.91 |
| Return On Networth / Equity (%) | -6.33 |
| Return On Networth /Employed (%) | -6.30 |
| Return On Assets (%) | -7.07 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.01 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 59.65 | 28.21 | 37.21 |
| Total Current Assets Annual | 57.71 | 246.14 | 241.26 |
| Non Current Assets Annual | 751.18 | 605.34 | 619.18 |
| Total Shareholders Funds Annual | 799.51 | 845.38 | 853.44 |
| Total Assets Annual | 808.89 | 851.48 | 860.44 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 59.65 |
| Total Current Assets Annual | 57.71 |
| Non Current Assets Annual | 751.18 |
| Total Shareholders Funds Annual | 799.51 |
| Total Assets Annual | 808.89 |
EPS (INR)
Expected
0.00
Reported
-2.36
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
